These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 26143621)

  • 1. Utilizing induced pluripotent stem cells (iPSCs) to understand the actions of estrogens in human neurons.
    Shum C; Macedo SC; Warre-Cornish K; Cocks G; Price J; Srivastava DP
    Horm Behav; 2015 Aug; 74():228-42. PubMed ID: 26143621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling neurodevelopmental disorders using human neurons.
    Chailangkarn T; Acab A; Muotri AR
    Curr Opin Neurobiol; 2012 Oct; 22(5):785-90. PubMed ID: 22717528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
    Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
    Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding neurodevelopmental disorders using human pluripotent stem cell-derived neurons.
    Tamburini C; Li M
    Brain Pathol; 2017 Jul; 27(4):508-517. PubMed ID: 28585386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Great Expectations: Induced pluripotent stem cell technologies in neurodevelopmental impairments.
    Zhang X; Li Z; Liu Y; Gai Z
    Int J Med Sci; 2021; 18(2):459-473. PubMed ID: 33390815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho Kinase Inhibition Is Essential During In Vitro Neurogenesis and Promotes Phenotypic Rescue of Human Induced Pluripotent Stem Cell-Derived Neurons With Oligophrenin-1 Loss of Function.
    Compagnucci C; Barresi S; Petrini S; Billuart P; Piccini G; Chiurazzi P; Alfieri P; Bertini E; Zanni G
    Stem Cells Transl Med; 2016 Jul; 5(7):860-9. PubMed ID: 27160703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.
    Vaccarino FM; Stevens HE; Kocabas A; Palejev D; Szekely A; Grigorenko EL; Weissman S
    Neuropharmacology; 2011 Jun; 60(7-8):1355-63. PubMed ID: 21371482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances for using human induced-pluripotent stem cells as pain-in-a-dish models of neuropathic pain.
    Labau JIR; Andelic M; Faber CG; Waxman SG; Lauria G; Dib-Hajj SD
    Exp Neurol; 2022 Dec; 358():114223. PubMed ID: 36100046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of patient-specific neurons in schizophrenia using induced pluripotent stem cells.
    Pedrosa E; Sandler V; Shah A; Carroll R; Chang C; Rockowitz S; Guo X; Zheng D; Lachman HM
    J Neurogenet; 2011 Oct; 25(3):88-103. PubMed ID: 21797804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the molecular basis of autism in a dish using hiPSCs-derived neurons from ASD patients.
    Lim CS; Yang JE; Lee YK; Lee K; Lee JA; Kaang BK
    Mol Brain; 2015 Sep; 8(1):57. PubMed ID: 26419846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
    Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
    Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Use of Induced Pluripotent Stem Cell Technology to Advance Autism Research and Treatment.
    Acab A; Muotri AR
    Neurotherapeutics; 2015 Jul; 12(3):534-45. PubMed ID: 25851569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling neurodevelopmental and psychiatric diseases with human iPSCs.
    Wen Z
    J Neurosci Res; 2017 May; 95(5):1097-1109. PubMed ID: 28186671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and mechanisms of melatonin on neural differentiation of induced pluripotent stem cells.
    Shu T; Wu T; Pang M; Liu C; Wang X; Wang J; Liu B; Rong L
    Biochem Biophys Res Commun; 2016 Jun; 474(3):566-571. PubMed ID: 27130826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling synaptogenesis in schizophrenia and autism using human iPSC derived neurons.
    Habela CW; Song H; Ming GL
    Mol Cell Neurosci; 2016 Jun; 73():52-62. PubMed ID: 26655799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling of psychiatric disorders using induced pluripotent stem cell-related technologies.
    Nakazawa T; Hashimoto R; Takuma K; Hashimoto H
    J Pharmacol Sci; 2019 Aug; 140(4):321-324. PubMed ID: 31257060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons.
    Cavallo F; Troglio F; Fagà G; Fancelli D; Shyti R; Trattaro S; Zanella M; D'Agostino G; Hughes JM; Cera MR; Pasi M; Gabriele M; Lazzarin M; Mihailovich M; Kooy F; Rosa A; Mercurio C; Varasi M; Testa G
    Mol Autism; 2020 Nov; 11(1):88. PubMed ID: 33208191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.